Lv11
72 积分 2024-05-27 加入
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
5小时前
已关闭
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
5小时前
已完结
Co-blocking TIGIT and PVRIG using a novel bispecific antibody enhances anti-tumor immunity
3天前
已完结
SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer HarboringBRAFG469A Mutation by Inhibiting the MAPK Signaling Pathway
16天前
已关闭
Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases
17天前
已完结
Predicting efficacy assessment of combined treatment of radiotherapy and nivolumab for NSCLC patients through virtual clinical trials using QSP modeling
1个月前
已完结
A novel human anti-TIGIT monoclonal antibody with excellent function in eliciting NK cell-mediated antitumor immunity
3个月前
已完结
Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis
4个月前
已完结
Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues
5个月前
已关闭
Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer
5个月前
已完结
皖公网安备34019202002308
